Home / Companies / Totus Medicines Inc / Trends
Totus Medicines Inc H-1B trends
Quarterly LCA aggregate trend points for Totus Medicines Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Totus Medicines Inc span 2022 Q2 to 2023 Q2, peaking at 2 filings in 2022 Q2.
The most recent reported period (2023 Q2) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2022 Q2 | 2 | 1 | 1 | $180,000 | $80,933 | 1 | 50.0% |
| 2023 Q1 | 1 | 1 | 1 | $115,000 | $111,072 | 1 | 100.0% |
| 2023 Q2 | 1 | 1 | 1 | $115,000 | $111,072 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Totus Medicines Inc changed over time?
- H-1B LCA filings for Totus Medicines Inc span 2022 Q2 to 2023 Q2, peaking at 2 filings in 2022 Q2. The most recent reported period (2023 Q2) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=totus+medicines+inc&metric=lca_countJSON